Stonehage Fleming Financial Services’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.13M | Hold |
4,500
| – | – | 0.04% | 68 |
|
|
2026
Q1 | $979K | Hold |
4,500
| – | – | 0.04% | 77 |
|
|
2025
Q4 | $1.03M | Hold |
4,500
| – | – | 0.03% | 65 |
|
|
2025
Q3 | $1.04M | Hold |
4,500
| – | – | 0.03% | 62 |
|
|
2025
Q2 | $835K | Hold |
4,500
| – | – | 0.02% | 75 |
|
|
2025
Q1 | $943K | Hold |
4,500
| – | – | 0.03% | 56 |
|
|
2024
Q4 | $800K | Sell |
4,500
-1,000
| -18% | -$184K | 0.02% | 68 |
|
|
2024
Q3 | $1.09M | Hold |
5,500
| – | – | 0.03% | 53 |
|
|
2024
Q2 | $943K | Buy |
5,500
+3,760
| +216% | +$623K | 0.03% | 59 |
|
|
2024
Q1 | $277K | Hold |
1,740
| – | – | 0.02% | 89 |
|
|
2023
Q4 | $270K | Hold |
1,740
| – | – | 0.01% | 118 |
|
|
2023
Q3 | $259K | Buy |
+1,740
| New | +$255K | 0.02% | 136 |
|
|
2023
Q2 | – | Sell |
-1,740
| Closed | -$277K | – | 200 |
|
|
2023
Q1 | $277K | Hold |
1,740
| – | – | 0.02% | 89 |
|
|
2022
Q4 | $281K | Hold |
1,740
| – | – | 0.02% | 92 |
|
|
2022
Q3 | $233K | Hold |
1,740
| – | – | 0.02% | 98 |
|
|
2022
Q2 | $266K | Hold |
1,740
| – | – | 0.01% | 133 |
|
|
2022
Q1 | $282K | Hold |
1,740
| – | – | 0.01% | 136 |
|
|
2021
Q4 | $235K | Hold |
1,740
| – | – | 0.01% | 150 |
|
|
2021
Q3 | $188K | Hold |
1,740
| – | – | 0.01% | 156 |
|
|
2021
Q2 | $196K | Hold |
1,740
| – | – | 0.01% | 140 |
|
|
2021
Q1 | $188K | Hold |
1,740
| – | – | 0.01% | 142 |
|
|
2020
Q4 | $186K | Hold |
1,740
| – | – | 0.01% | 143 |
|
|
2020
Q3 | $152K | Hold |
1,740
| – | – | 0.01% | 131 |
|
|
2020
Q2 | $170K | Hold |
1,740
| – | – | 0.01% | 102 |
|
|
2020
Q1 | $133K | Hold |
1,740
| – | – | 0.01% | 133 |
|
|
2019
Q4 | $154K | Hold |
1,740
| – | – | 0.01% | 137 |
|
|
2019
Q3 | $132K | Hold |
1,740
| – | – | 0.01% | 136 |
|
|
2019
Q2 | $127K | Hold |
1,740
| – | – | 0.01% | 131 |
|
|
2019
Q1 | $140K | Hold |
1,740
| – | – | 0.01% | 143 |
|
|
2018
Q4 | $160K | Hold |
1,740
| – | – | 0.01% | 172 |
|
|
2018
Q3 | $165K | Hold |
1,740
| – | – | 0.01% | 173 |
|
|
2018
Q2 | $161K | Hold |
1,740
| – | – | 0.01% | 177 |
|
|
2018
Q1 | $165K | Hold |
1,740
| – | – | 0.01% | 166 |
|
|
2017
Q4 | $168K | Hold |
1,740
| – | – | 0.01% | 177 |
|
|
2017
Q3 | $155K | Hold |
1,740
| – | – | 0.01% | 186 |
|
|
2017
Q2 | $126K | Hold |
1,740
| – | – | 0.01% | 190 |
|
|
2017
Q1 | $113K | Hold |
1,740
| – | – | 0.01% | 231 |
|
|
2016
Q4 | $109K | Hold |
1,740
| – | – | 0.01% | 236 |
|
|
2016
Q3 | $110K | Buy |
+1,740
| New | +$113K | 0.01% | 226 |
|
Other funds holding ABBV
Stonehage Fleming Financial Services's ABBV Position: Q2 2026 in Review
Stonehage Fleming Financial Services held its AbbVie (ABBV) position steady in Q2 2026 at 4,500 shares worth $1.13M. The position accounts for 0.04% of the portfolio, ranked #68.
Stonehage Fleming Financial Services first reported a position in ABBV in Q3 2016 and has held it in 39 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Stonehage Fleming Financial Services held 4,500 shares of AbbVie worth $1.13M as of Q2 2026.
- Stonehage Fleming Financial Services left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 0.04% of Stonehage Fleming Financial Services's portfolio in Q2 2026, its #68 holding.
- Stonehage Fleming Financial Services first reported a position in AbbVie in Q3 2016 and has held it in 39 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Stonehage Fleming Financial Services's 13F filing for Q2 2026, filed 17 Aug 2026.